Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gene ldh, encoding
L-lactate dehydrogenase
(LDH;
EC 1.1.1.27
) of Bifidobacterium longum aM101-2, was cloned in Escherichia coli using an oligodeoxyribonucleotide hybridization probe. The amino acid (aa) sequence, deduced from the sequence of the cloned DNA, was consistent with the results of protein chemical analysis of B. longum LDH. The transcription start points (tsp) in B. longum were identified by
S1 nuclease
mapping. A sequence, GTAGCAA-(14 bp)-TTATAGA, which is located a few bp upstream from the tsp, was assigned as the promoter of this ldh gene. In the 3'-noncoding region, there were two structures that strongly resembled the Rho-independent transcriptional termination signal of E. coli. Therefore, the B. longum ldh gene might form a monocistronic unit. The deduced primary structure of B. longum LDH had 40% identity with LDHs from Thermus caldophilus, Bacillus stearothermophilus, Lactobacillus casei and dogfish muscle. Most bacterial LDHs are allosterically regulated by fructose 1,6-bisphosphate (FBP), while the vertebrate LDHs are not. The anion-binding site of vertebrate LDHs has been thought to correspond to the FBP-binding site of bacterial LDHs. Although the B. longum LDH was regulated by FBP, the charge properties of aa residues in the putative FBP-binding site of the LDH were closer to those of the vertebrate LDHs than to those of bacterial LDHs.
...
PMID:Sequence and characteristics of the Bifidobacterium longum gene encoding L-lactate dehydrogenase and the primary structure of the enzyme: a new feature of the allosteric site. 269 96
The yeast L(+)-lactate cytochrome c oxidoreductase or cytochrome b2 is a component of the mitochondrial intermembrane space. The protein is encoded by the nuclear genome, synthesized as a larger precursor in the cytoplasmic compartment, and then proteolytically processed to its mature form during its import into the mitochondria. The structural gene for yeast cytochrome b2 has been cloned. The complete nucleotide sequence of the gene with its 5' and 3' flanking regions was determined. The deduced primary structure of the cytochrome b2 precursor reveals an unusually long amino terminal extension of 80 amino acids. A variety of potentially significant sequences were identified in the region flanking the structural portion of the gene. Transcript mapping with both
S1 nuclease
and primer extension methods reveals that the site of RNA synthesis is 56-66 bp downstream from a putative TATA box. By Northern blot analysis and gene disruption, it is shown that there is only a single copy of the cytochrome b2 gene per haploid yeast nucleus. The cloned cytochrome b2 gene was used to probe specific mRNA levels and demonstrate that cytochrome b2 expression is transcriptionally repressed by glucose and induced by lactate. The inactivation of the chromosomal cytochrome b2 gene by integrative transformation led to a deficiency in L(+)-
lactate dehydrogenase
activity and consequently to the inability to use L(+)-lactate as a sole source of carbon. This is the first reported mutation affecting the structural gene of cytochrome b2.
...
PMID:Structure, expression and regulation of a nuclear gene encoding a mitochondrial protein: the yeast L(+)-lactate cytochrome c oxidoreductase (cytochrome b2). 300 48